ArticleCritical care explorations2025
Early Risk Stratification of Patients After Successfully Resuscitated Out-of-Hospital Cardiac Arrest Without ST-Segment Elevation-The Angiography After Out-of-Hospital Cardiac Arrest Without ST-Segment Elevation (TOMAHAWK) Risk Score.
Article in Critical care explorations, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesExisting scores for risk stratification after out-of-hospital cardiac arrest (OHCA) are either medically outdated, limited to registry data, small cohorts, and certain healthcare systems only, or include rather complex calculations. The objective of this study was to develop an easy-to-use risk prediction score for short-term mortality in patients with successfully resuscitated OHCA without ST-segment elevation on the post-resuscitation electrocardiogram, derived from the Angiography after Out-of-Hospital Cardiac Arrest without ST-Segment Elevation (TOMAHAWK) trial. The risk score was externally validated in the Coronary Angiography after Cardiac Arrest Trial (COACT) cohort (shockable arrest rhythms only) and additional hospitals from Berlin, Germany (shockable and nonshockable arrest rhythms).
designPredefined subanalysis of the TOMAHAWK trial.
settingDevelopment and external validation across 52 centers in three countries. PATIENTS: Adult patients with successfully resuscitated OHCA and no ST-segment elevations.
interventionsUtilization of the TOMAHAWK risk score upon hospital admission. MEASUREMENTS AND MAIN
resultsThe risk score was developed using a backward stepwise regression analysis. Between one and four points were attributed to each variable in the risk score, resulting in a score with three risk categories for 30-day mortality: low (0-2), intermediate (3-6), and high (7-10). Five variables emerged as independent predictors for 30-day mortality and were used as risk score parameters: age of 72 years old or older, known diabetes, unshockable initial electrocardiogram rhythm, time until return of spontaneous circulation greater than or equal to 23 minutes, and admission arterial lactate level greater than or equal to 8 mmol/L. The 30-day mortality rates for each risk category were 23.6%, 68.8%, and 86.2%, respectively (p < 0.001) with a good discrimination at an area under the curve of 0.82. External validation in the COACT and Berlin cohorts showed short-term mortality rates of 23.1% and 20.4% (score 0-2), 44.8% and 48.1% (score 3-6), and 78.9% and 73.3% (score 7-10), respectively (each p < 0.001).
conclusionsThe TOMAHAWK risk score can be easily calculated in daily clinical practice and strongly correlated with mortality in patients with successfully resuscitated OHCA without ST-segment elevation on post-resuscitation electrocardiogram.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.